The Asia Pacific Prosthetic Heart Valve Market would witness market growth of 11.2% CAGR during the forecast period (2022-2028).
Valve replacement is becoming more common all over the world, and it has drastically improved the outcomes of valvular heart disease patients. Bioprosthetic valves have a good hemodynamic function, but they are prone to structural valve deterioration, which necessitates reintervention. Mechanical valves, on the other hand, provide long-term durability but necessitate lifelong anticoagulation, which carries the risk of bleeding and thrombosis. The benefits and risks of each type of prosthetic valve should be carefully considered, and patient preference should be considered as part of a joint decision-making process.
Framework-based surgical valve transplant or transcatheter implant of a prosthetic heart valve has been linked to enhanced survival and symptom reduction in patients with acute valvular heart disease. Mechanical and bioprosthetic, also known as tissue, valves are two types of prosthetic heart valves that are designed to mimic the function of native valves by ensuring unidirectional blood flow. Every type has its own set of drawbacks and benefits.
A significant scale of geriatric population in the region is one of the major factors that are driving the growth of the regional market. China's elderly population is expanding at a faster rate than the rest of the countries' population. The number of people over the age of 65 increased from 42 million in 1953 to 72 million in 1978. The aged population in cities is expanding at a faster rate than the old population in rural areas. China's old population was expected to increase to 11% by the end of the century and 20% by 2025. A higher quality of living and health care, a lowering birth rate, longer life expectancy, and an aging population born in the last 30 years are all factors contributing to the rise in the old population.
In addition, In the last 50 years, India, the world's second most populous country, has seen a tremendous demographic shift, with nearly a tripling of the citizens over the age of 60. This trend is likely to continue. The number of Indians aged 60 and older is expected to climb from 7.5% to 11.1% in 2025, according to projections (United Nations Department of Economic and Social Affairs. India had more than 91.6 million elderly in 2010, according to UNDESA data on the projected population age structure, with an annual addition of 2.5 million elderly between 2005 and 2010. The elderly population in India is estimated to reach 158.7 million in 2025 surpassing the population of children under the age of 14 by 2050.
The China market dominated the Asia Pacific Prosthetic Heart Valve Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,123.1 million by 2028. The Japan market is anticipated to grow at a CAGR of 10.6% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 11.9% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals & Cardiac Centers and Ambulatory Surgical Centers & Others. Based on Product, the market is segmented into Transcatheter, Tissue, and Mechanical. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Prosthetic Heart Valve Market is Projected to reach USD 13.3 Billion by 2028, at a CAGR of 10.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Meril Life Science Private Limited, Colibri Heart Valve LLC, Artivion, Inc., TTK Healthcare Limited, Edwards Lifesciences Corporation, JenaValve Technology, Inc., and Micro Interventional Devices, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Hospitals & Cardiac Centers
- Ambulatory Surgical Centers & Others
By Product
- Transcatheter
- Tissue
- Mechanical
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- Medtronic PLC
- Abbott Laboratories
- Meril Life Science Private Limited
- Colibri Heart Valve LLC
- Artivion, Inc.
- TTK Healthcare Limited
- Edwards Lifesciences Corporation
- JenaValve Technology, Inc.
- Micro Interventional Devices, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Prosthetic Heart Valve Market, by End User
1.4.2 Asia Pacific Prosthetic Heart Valve Market, by Product
1.4.3 Asia Pacific Prosthetic Heart Valve Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Approvals and Trials
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2019, Mar – 2021, Oct) Leading Players
Chapter 4. Asia Pacific Prosthetic Heart Valve Market by End User
4.1 Asia Pacific Hospitals & Cardiac Centers Market by Country
4.2 Asia Pacific Ambulatory Surgical Centers & Others Market by Country
Chapter 5. Asia Pacific Prosthetic Heart Valve Market by Product
5.1 Asia Pacific Transcatheter Market by Country
5.2 Asia Pacific Tissue Market by Country
5.3 Asia Pacific Mechanical Market by Country
Chapter 6. Asia Pacific Prosthetic Heart Valve Market by Country
6.1 China Prosthetic Heart Valve Market
6.1.1 China Prosthetic Heart Valve Market by End User
6.1.2 China Prosthetic Heart Valve Market by Product
6.2 Japan Prosthetic Heart Valve Market
6.2.1 Japan Prosthetic Heart Valve Market by End User
6.2.2 Japan Prosthetic Heart Valve Market by Product
6.3 India Prosthetic Heart Valve Market
6.3.1 India Prosthetic Heart Valve Market by End User
6.3.2 India Prosthetic Heart Valve Market by Product
6.4 South Korea Prosthetic Heart Valve Market
6.4.1 South Korea Prosthetic Heart Valve Market by End User
6.4.2 South Korea Prosthetic Heart Valve Market by Product
6.5 Singapore Prosthetic Heart Valve Market
6.5.1 Singapore Prosthetic Heart Valve Market by End User
6.5.2 Singapore Prosthetic Heart Valve Market by Product
6.6 Malaysia Prosthetic Heart Valve Market
6.6.1 Malaysia Prosthetic Heart Valve Market by End User
6.6.2 Malaysia Prosthetic Heart Valve Market by Product
6.7 Rest of Asia Pacific Prosthetic Heart Valve Market
6.7.1 Rest of Asia Pacific Prosthetic Heart Valve Market by End User
6.7.2 Rest of Asia Pacific Prosthetic Heart Valve Market by Product
Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Acquisition and Mergers:
7.1.6 SWOT Analysis
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.2.6 SWOT Analysis
7.3 Abbott Laboratories
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.5.2 Acquisition and Mergers:
7.3.5.3 Approvals and Trials:
7.3.6 SWOT Analysis
7.4 Meril Life Sciences Private Limited
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Product Launches and Product Expansions:
7.5 Colibri Heart Valve LLC
7.5.1 Company Overview
7.6 Artivion, Inc. (CryoLife, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Acquisition and Mergers:
7.7 TTK Healthcare Limited
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 Edwards Lifesciences Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.8.5.2 Approvals and Trials:
7.9 JenaValve Technology, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Geographical Expansions:
7.10. Micro Interventional Devices, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Approvals and Trials:
TABLE 1 Asia Pacific Prosthetic Heart Valve Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Prosthetic Heart Valve Market, 2022 - 2028, USD Million
TABLE 3 Approvals and Trials – Prosthetic Heart Valve Market
TABLE 4 Product Launches And Product Expansions – Prosthetic Heart Valve Market
TABLE 5 Acquisition and Mergers – Prosthetic Heart Valve Market
TABLE 6 Asia Pacific Prosthetic Heart Valve Market by End User, 2018 - 2021, USD Million
TABLE 7 Asia Pacific Prosthetic Heart Valve Market by End User, 2022 - 2028, USD Million
TABLE 8 Asia Pacific Hospitals & Cardiac Centers Market by Country, 2018 - 2021, USD Million
TABLE 9 Asia Pacific Hospitals & Cardiac Centers Market by Country, 2022 - 2028, USD Million
TABLE 10 Asia Pacific Ambulatory Surgical Centers & Others Market by Country, 2018 - 2021, USD Million
TABLE 11 Asia Pacific Ambulatory Surgical Centers & Others Market by Country, 2022 - 2028, USD Million
TABLE 12 Asia Pacific Prosthetic Heart Valve Market by Product, 2018 - 2021, USD Million
TABLE 13 Asia Pacific Prosthetic Heart Valve Market by Product, 2022 - 2028, USD Million
TABLE 14 Asia Pacific Transcatheter Market by Country, 2018 - 2021, USD Million
TABLE 15 Asia Pacific Transcatheter Market by Country, 2022 - 2028, USD Million
TABLE 16 Asia Pacific Tissue Market by Country, 2018 - 2021, USD Million
TABLE 17 Asia Pacific Tissue Market by Country, 2022 - 2028, USD Million
TABLE 18 Asia Pacific Mechanical Market by Country, 2018 - 2021, USD Million
TABLE 19 Asia Pacific Mechanical Market by Country, 2022 - 2028, USD Million
TABLE 20 Asia Pacific Prosthetic Heart Valve Market by Country, 2018 - 2021, USD Million
TABLE 21 Asia Pacific Prosthetic Heart Valve Market by Country, 2022 - 2028, USD Million
TABLE 22 China Prosthetic Heart Valve Market, 2018 - 2021, USD Million
TABLE 23 China Prosthetic Heart Valve Market, 2022 - 2028, USD Million
TABLE 24 China Prosthetic Heart Valve Market by End User, 2018 - 2021, USD Million
TABLE 25 China Prosthetic Heart Valve Market by End User, 2022 - 2028, USD Million
TABLE 26 China Prosthetic Heart Valve Market by Product, 2018 - 2021, USD Million
TABLE 27 China Prosthetic Heart Valve Market by Product, 2022 - 2028, USD Million
TABLE 28 Japan Prosthetic Heart Valve Market, 2018 - 2021, USD Million
TABLE 29 Japan Prosthetic Heart Valve Market, 2022 - 2028, USD Million
TABLE 30 Japan Prosthetic Heart Valve Market by End User, 2018 - 2021, USD Million
TABLE 31 Japan Prosthetic Heart Valve Market by End User, 2022 - 2028, USD Million
TABLE 32 Japan Prosthetic Heart Valve Market by Product, 2018 - 2021, USD Million
TABLE 33 Japan Prosthetic Heart Valve Market by Product, 2022 - 2028, USD Million
TABLE 34 India Prosthetic Heart Valve Market, 2018 - 2021, USD Million
TABLE 35 India Prosthetic Heart Valve Market, 2022 - 2028, USD Million
TABLE 36 India Prosthetic Heart Valve Market by End User, 2018 - 2021, USD Million
TABLE 37 India Prosthetic Heart Valve Market by End User, 2022 - 2028, USD Million
TABLE 38 India Prosthetic Heart Valve Market by Product, 2018 - 2021, USD Million
TABLE 39 India Prosthetic Heart Valve Market by Product, 2022 - 2028, USD Million
TABLE 40 South Korea Prosthetic Heart Valve Market, 2018 - 2021, USD Million
TABLE 41 South Korea Prosthetic Heart Valve Market, 2022 - 2028, USD Million
TABLE 42 South Korea Prosthetic Heart Valve Market by End User, 2018 - 2021, USD Million
TABLE 43 South Korea Prosthetic Heart Valve Market by End User, 2022 - 2028, USD Million
TABLE 44 South Korea Prosthetic Heart Valve Market by Product, 2018 - 2021, USD Million
TABLE 45 South Korea Prosthetic Heart Valve Market by Product, 2022 - 2028, USD Million
TABLE 46 Singapore Prosthetic Heart Valve Market, 2018 - 2021, USD Million
TABLE 47 Singapore Prosthetic Heart Valve Market, 2022 - 2028, USD Million
TABLE 48 Singapore Prosthetic Heart Valve Market by End User, 2018 - 2021, USD Million
TABLE 49 Singapore Prosthetic Heart Valve Market by End User, 2022 - 2028, USD Million
TABLE 50 Singapore Prosthetic Heart Valve Market by Product, 2018 - 2021, USD Million
TABLE 51 Singapore Prosthetic Heart Valve Market by Product, 2022 - 2028, USD Million
TABLE 52 Malaysia Prosthetic Heart Valve Market, 2018 - 2021, USD Million
TABLE 53 Malaysia Prosthetic Heart Valve Market, 2022 - 2028, USD Million
TABLE 54 Malaysia Prosthetic Heart Valve Market by End User, 2018 - 2021, USD Million
TABLE 55 Malaysia Prosthetic Heart Valve Market by End User, 2022 - 2028, USD Million
TABLE 56 Malaysia Prosthetic Heart Valve Market by Product, 2018 - 2021, USD Million
TABLE 57 Malaysia Prosthetic Heart Valve Market by Product, 2022 - 2028, USD Million
TABLE 58 Rest of Asia Pacific Prosthetic Heart Valve Market, 2018 - 2021, USD Million
TABLE 59 Rest of Asia Pacific Prosthetic Heart Valve Market, 2022 - 2028, USD Million
TABLE 60 Rest of Asia Pacific Prosthetic Heart Valve Market by End User, 2018 - 2021, USD Million
TABLE 61 Rest of Asia Pacific Prosthetic Heart Valve Market by End User, 2022 - 2028, USD Million
TABLE 62 Rest of Asia Pacific Prosthetic Heart Valve Market by Product, 2018 - 2021, USD Million
TABLE 63 Rest of Asia Pacific Prosthetic Heart Valve Market by Product, 2022 - 2028, USD Million
TABLE 64 key Information – Boston Scientific Corporation
TABLE 65 Key Information – Medtronic PLC
TABLE 66 Key Information – Abbott Laboratories
TABLE 67 Key Information – Meril Life Sciences Private Limited
TABLE 68 Key Information – Colibri Heart Valve LLC
TABLE 69 Key Information – Artivion, Inc.
TABLE 70 Key Information – TTK Healthcare Limited
TABLE 71 Key Information – Edwards Lifesciences Corporation
TABLE 72 Key Information – JenaValve Technology, Inc.
TABLE 73 Key Information – Micro Interventional Devices, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2019, Mar – 2021, Oct) Leading Players
FIG 5 Recent strategies and developments: Boston Scientific Corporation
FIG 6 SWOT Analysis: Boston Scientific Corporation
FIG 7 Swot analysis: Medtronic plc
FIG 8 Recent strategies and developments: Abbott Laboratories
FIG 9 Swot analysis: Abbott laboratories